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Abstract 
Objective 
Only a few small studies have been published on pregnancies after total hip replacement (THR), and they 
have reported no adverse pregnancy outcomes after THR. The aim of our study was to evaluate whether 
maternal THR affects pregnancy outcomes on a population-based level. 
Study Design 
Data for this nationwide register-based cohort study have been collected from four national registries in 
Finland from 1980 to 2007. All females who had undergone THR during that period formed the patient 
group, and three controls for each patient without THR were selected. Patient group comprised 2429 
women, 719 (29.6%) of whom had 1190 pregnancies ending in singleton deliveries. Of those births, 986 
were before THR and 204 after THR. The control group comprised 7276 women, 2805 (38.6%) of whom had 
5112 pregnancies ending in singleton deliveries, 3695 occurred before the index date (time point when THR 
took place within the patient group) and 1417 after. Logistic regression model was used to analyze 
univariable and adjusted odds ratios (aOR) for adverse neonatal outcomes after maternal THR compared 
with controls. Data were adjusted using the following variables: maternal age, smoking, rheumatoid 
arthritis.  
Results 
Stillbirth was more common in the patient group compared with control group 4 (2.0%) vs 8 (0.6%) p=0.02. 
Moreover, neonates in the patient group were more likely to be born preterm (aOR 3.58, p=<0.001), small 
for gestational age (aOR 2.83, p=0.006) and low birthweight (aOR 4.79, p=<0.001), compared to control 
group. Trial of labor more likely ended in emergency cesarean section in the patient group than in the 
control group 39 (28.9%) vs 150 (11.6%), p=<0.001. Adverse pregnancy outcome was more common after 
THR also when compared to pregnancies before THR. 
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Neonates born after maternal total hip replacement have an increased risk of stillbirth, small for gestational 
age, low birthweight and preterm birth. Trial of labor is more likely to end in emergency cesarean section. 
Keywords 
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Introduction 
Total hip replacement (THR) is a highly effective operation for decreasing pain and improving quality of 
life in affected individuals (1). The most common indications for THR in fertile-aged patients  are 
rheumatoid arthritis (RA), avascular necrosis of the femoral head and developmental dysplasia of the hip 
(2,3). In Finland, the annual incidence of primary THR among 30 to 39 year olds was 59.5 per 100 000 
person years in 2007(4). The prevalence of THR in Sweden in 1999 was 12 per 100 000 women aged under 
40 years and 19 per 100 000 in 2012 (5). In the United States, it has been estimated that the annual primary 
THR rate in the less than 45 years old group  could possibly increase 3-fold by 2030 compared with 2006 
rates (6). 
There have only been a few studies that have evaluated the effect of previous THR on later pregnancy 
and delivery or vice versa. The results of these previous studies have not shown an increased risk for 
complications in delivery after THR, although the numbers of included patients in these studies have been 
small (n= 10 to 50).(7-14) Interestingly, some of these studies have reported an increased rate of cesarean 
sections (CS) after THR (10,13,15).  
Some studies have raised concerns regarding elevated fetal blood metal ion (chromium and cobalt) 
levels in women with metal-on-metal hip replacements and the possible passage of the metal ions to the 
fetus via the placenta. (16-18). Most of the case reports, however, have not shown any teratogenic impact, 
despite elevated placental blood metal ion levels (18-20). Two case reports have described a neonate with 
high metal ion levels combined with congenital anomalies (21). Considering the previous literature, women 
may still have concerns regarding pregnancy and vaginal delivery after THR operation (11). 
The aim of this present study was to evaluate the effect of THR on the delivery and health of neonates 
on a population-based level using data routinely recorded into national health registers in Finland.  
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The study population in this register-based nationwide cohort study was gathered from four different 
national registers in Finland. Information on all women aged 15 to 45 years who had undergone primary 
THR between 1980 and 2007 was retrieved from the Finnish Arthroplasty Register and included in this 
study (n=2429 women with primary THRs). The register was established in 1980 and is maintained by the 
National Institute for Health and Welfare. The coverage of the register has been high over the years, 
especially with regard to primary THR (approximately 95%), and it matches well with the hospital discharge 
register data(22). Based on the bearing material, the type of implant was categorized as either metal-on-
metal or not metal-on-metal. 
For each patient included in the patient group, three control women without THR matched by age at 
the time of THR and place of residence were obtained from the Finnish Population Information System 
maintained by the Population Register Centre and formed the control group (n= 7276 control women 
without THR). The start of the follow-up was the date of THR operation in the THR group and the operation 
date was the index date for the matching controls. The common closing date for this study was 31st 
December 2007.  
In this study, information on singleton pregnancies and deliveries for both groups was gathered from 
the national Medical Birth Register, which was established in 1987. The register is maintained by the 
National Institute for Health and Welfare and contains information on all pregnancies ending in birth or 
stillbirth after gestational week 22 and neonates weighing over 500 grams. The Medical Birth Register also 
contains the background characteristics of the pregnancies and basic information on deliveries and neonate 
outcome up to hospital discharge or seven days postpartum.(23)  
Of the 2429 women in the patient group, 719 (29.6%) had 1190 pregnancies ending in singleton 
deliveries. Of these, 575 women had 986 singleton deliveries prior to THR, and 144 women had 204 
singleton deliveries after THR. The control group comprised 7276 women, 2805 (38.6%) of whom had 5112 
pregnancies ending in singleton deliveries. Of these, a total of 1893 women had 3695 singleton deliveries 
before the index date, and 912 women had 1417 singleton deliveries after the index date. The deliveries 
Materials and methods 
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after THR/index date were included in the analysis. In addition, a subgroup comparison in the patient group 
was performed for before and after THR deliveries (Figure 1) 
Information on long-term chronic diseases was obtained from the Register of Medical 
Reimbursements that is maintained by the Social Insurance Institution of Finland and contains information 
on reimbursable medical costs for chronic diseases. Reimbursements for medical costs are granted with a 
medical certificate issued by a licensed doctor. Information on the most common long-term disease, RA, 
among the study population was obtained, and those persons who did not have a reimbursement for RA 
medication in the register were classified as not having RA.  
Standard deviations (SD) for birth weight and birth length were calculated by using the new Finnish 
growth references for male and female children and adolescents. (24) A SD of less than -2.0 from mean was 
considered as small for gestational age (SGA), and a SD greater than +2.0 from mean was considered as 
large for gestational age (LGA). Standard deviations were calculated for all neonates. Neonates born before 
gestational week 37+0 were defined as preterm. Neonates weighing less than 2 500 grams were defined as 
low birthweight (LBW). 
All the singleton pregnancies were observed and compared between the groups. Chi-squared test was 
used to analyze intergroup differences in the categorical variables between the patient group and the 
control group. A p-value under 0.05 was considered statistically significant. Confidence intervals (95% CI) 
for the difference of the two proportions were used when comparing before and after THR proportions in 
the patient group. Means with SD´s were calculated for normally distributed variables and medians with 
interquartile ranges for non-normally distributed variables. Logistic regression model was used to calculate 
odds ratios (OR) with 95% CI to compare adverse pregnancy outcomes between the patient and control 
groups. The following covariates from the available variates in the registers were included and selected 
based on the previous literature in the adjusted model: maternal age, smoking during pregnancy and 
maternal RA. Statistical analyses were performed using IBM SPSS for Windows, version 24.0 software.  
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 All the data were linked by using the individual personal identification code that is issued to all 
permanent residents of Finland. No written consent was required since none of the participants were 
contacted, and hence no approval from the local ethical committee was required. However, our study 
protocol did undergo ethical evaluation by the National Institute for Health and Welfare in order to gain 
access to register data, permission number: THL/599/5.05.00/2010.  
Results 
Women in the patient group were older at the time of delivery compared with the control group. A 
higher proportion of women had their first pregnancy after THR in the patient group. In 42 % of the 
deliveries in the patient group, the mother had RA. Baseline information and background characteristics of 
the pregnant women are presented in Table 1. 
 Stillbirth was more common in the patient group compared with the control group (Table 2). In the 
patient group, neonates had a lower birthweight and birth length. The neonates born in this group were 
also more likely to be born preterm compared with the control group. In addition, neonates born after THR 
also had higher LBW and SGA proportions and needed more neonatal intensive care treatment and 
phototherapy compared with the control group (Table 2). When these findings were adjusted with 
potential confounders, THR remained an independent risk factor in the patient group for preterm birth, 
LBW and SGA, but not for stillbirth (Table 3). 
The pregnancies in the patient group were also compared to pregnancies before THR. Our findings 
showed adverse pregnancy outcomes were more common after THR than before THR. Moreover, the rates 
of stillbirth (2.0% vs 0.3%, p=0.004), SGA neonates (8.3% vs 3.3%, p=0.001) and preterm births (13.7% vs 
7.1%, p=0.001) were all found to be higher after THR.   
In subgroup analysis, deliveries with maternal metal-on-metal THRs (n=16) were compared with 
deliveries with non-metal-on-metal THRs (n=188). The groups had similar rates of stillbirths (0.0% vs 2.1%, 
p=1.00), preterm births (25.0% vs 12.8%, p=0.25) and LBW neonates (18.8% vs 11.7%, p=0.42). In addition, 
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neonates born to mothers with metal-on-metal THR were more likely to be SGA compared with those born 
to mothers with non-metal-on-metal THR (25.0% vs 6.9%, p=0.03).  
 The proportion of elective cesarean sections (CS) was higher in the patient group than in the control 
group (Table 2). The overall proportion of CS was 27% before THR and 53% after THR and trial of labor 
more often resulted in emergency CS. The use of epidural analgesia and amniotomies were more common 
in the control group (Table 4).  
Discussion 
The results of this study raise concerns over adverse pregnancy outcomes, such as preterm birth, LBW, 
SGA and stillbirth, that were found to be more common in women after THR than in the control group 
without THR. 
In Finland, the national stillbirth rate has been between 3 to 5 per 1000 births for the last 30 years.(23) 
The stillbirth rate of the control group, as well as the patient group before THR, was similar to national 
levels, but in the patient group after THR it was four to five times higher. One reason for the increased 
stillbirth rate might be the underlying diseases of the THR patients. Two of the four women with stillbirth in 
the patient group had RA. RA has been shown to increase the risk of preterm birth and SGA neonate, but 
not for stillbirths or perinatal mortality in large cohort studies (25-27). However, the prevalence of RA was 
also high in the patient group before THR. 
Some studies have described the possible effects of the ion release of metal-on-metal implants on 
fetal health. Chromium and cobalt have been shown to be toxic, but it is believed that the increased blood 
metal ion concentration remains below teratogenic levels. The placenta also prevents a large proportion of 
the ions from entering the fetal circulation (18,20). Although the concentrations of metal ions may remain 
below teratogenic levels, the slightly elevated fetal blood metal ion level might influence the growth of the 
fetus and be involved in preterm births or stillbirths. Metal-on-metal implants gained popularity in Finland 
in the year 2000 and were widely used for the following 10 years. In this study, only the rate of SGA was 
significantly higher among metal-on-metal implants compared with non-metal-on-metal implants, but the 
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same trend was also noted in other outcome measures. However, the number of patients with metal-on-
metal THR was low in this study. Furthermore, no information on maternal metal ion levels was available. 
The intended modes of delivery differed between groups. Women in the THR group had more elective 
CS and fewer trials of labor.  One explanation for the higher rate of elective CS could be that patients with a 
replaced hip opt to have elective CS because of a possible fear of damaging the THR implant and negatively 
affecting the delivery outcome in vaginal delivery (10,13,15). Women in the THR group already had higher 
CS proportions before THR compared with the control group, which might be explained by their underlying 
diseases. A German cohort study showed that women with chronic diseases were more likely to deliver by 
CS than healthy referents(23).  
The trials of labor were more likely to result in acute CS compared with the control group. It remains 
unclear whether this finding was because of abnormalities in cardiotocography or prolonged labor as this 
information was not available. It is also possible that not all THR patients classified as having a trial of labor 
were really opting for vaginal delivery. The small percentage of epidural analgesia and amniotomies after 
THR may be explained by the possibility that a considerable number of parturients in that group had 
actually planned elective CS, but it had been converted to emergency CS for reasons such as early onset of 
labor. Our results differ from those of the largest previous study by Sierra et al. who observed a total of 47 
deliveries after THR and suggested that the percentage of CS (35.0%) in their patient series did not differ 
from national levels(11). A couple of smaller patient series also reported similar CS rates compared to 
national rates in their studies (28-30), while some smaller studies have reported increased rates of CS 
(41.1%-100%) (10,13,15). However, none of these previous studies have had control groups without THRs. 
One of the main strengths of this study is the large, nationwide study population with long study 
period. A further strength is that this is also the first study to compare post-operative deliveries to both 
preoperative deliveries and matching controls. Moreover, a register-based study design further eliminates 
any possible recall-bias. One of the benefits of these registers is their good coverage so that the data 
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represents well the defined population. The register data are routinely collected using structured forms 
with nationwide instructions that reduce possible reporting bias.  
A long study period is one complicating factor when analyzing deliveries and neonatal outcomes. 
During the 20-year study period, delivery methods and neonatal care changed, as did the medications used 
for the treatment of RA. Moreover, there were some important missing variables in the MBR. For example, 
information on previous preterm deliveries or previous SGA children was not available. In addition, no 
information on body mass index was recorded before 2004, and the register data only had information on 
1-minute Apgar-scores, since 5-minute scores only became part of the register in 2004. Also, durations of 
labor stages were not found in most of the cases, since they also became part of the register in 2004. 
According to the findings of this study, adverse pregnancy outcome (preterm birth, LBW, SGA and 
stillbirth) are more common in women who have undergone THR. As a result, such women are more likely 
to have elective and emergency cesarean sections after THR. Further studies with combined multinational 
registries would be needed to confirm these novel findings. 
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Figure and Table legends 
Figure 1 Flow chart of study population.  Index date is the date of THR. Deliveries of the patient group were 
classified as taking place before or after THR, and likewise the deliveries of the control group were matched 
according to the index date.   
Table 1 Background characteristics of women having singleton pregnancies ending in delivery in the patient 
group and in the control group 
Table 2 Perinatal characteristics and outcome in the patient group after THR and the control group 
Table 3 Univariable and adjusted Odds ratios (OR) with 95% confidence intervals (CI) for pregnancy 
outcomes. Data were adjusted by the following variables: maternal age at delivery, smoking during 
pregnancy and maternal rheumatoid arthritis. 
Table 4 proportions of obstetric variables in attempted vaginal deliveries for the patient group and the 
control group. 
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Figure 1 Flow chart of study population and deliveries in patient group (women with total hip replacement 
(THR) and control group.  Index date is the date of THR. Deliveries of the patient group were classified as 
taking place before or after THR, and likewise the deliveries of the control group were matched according 
to the index date.   
Patient group 
2,429 women 
986 singleton 
deliveries  
Index date THR (Index 
date) 
575 women 2,805 women 144 women 
204 singleton 
deliveries  
912 women 
Control group 
7,276 women 
1,417 singleton 
deliveries  
5,112 singleton 
deliveries  
before after after before 
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Table 1 
Patient group Control group 
Total number 204 1417 
n % n % P 
Age at birth (years, mean SD) 33.4 5.2 32.6 5.2 0.046 
Nulliparous  80 39.2 438 31.0 0.02 
Previous cesarean section 37 18.1 161 11.4 0.006 
Marital status 
never married 28 13.7 205 14.5 0.78 
 ever married 176 86.3 1212 85.5 
Maternal smoking 
non-smoker 173 84.1 1191 84.1 0.63 
quit during 1st trimester 4 2.0 43 3.0 
Smoker 25 12.3 142 10.0 
unknown 2 1.0 41 2.9 
Rheumatoid arthritis 86 42.2 6 0.4 <0.001 
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Table 2 
Patient group Control group 
Total number 204 1417 
n % n % p 
Intended mode of delivery 
Elective CS 69 33.8 124 8.8 <0.001 
Trial of labor  135 66.2 1293 91.2 
Fetal gender male 103 50.5 730 51.5 0.78 
Birth length (cm) (mean; SD) 48.7 2.8 50.3 2.6 <0.001 
Birth weight (grams) (mean; 
SD) 
3240 670 3580 560 <0.001 
LBW <2500g 25 12.3 41 2.9 <0.001 
SGA 17 8.3 39 2.8 <0.001 
LGA 3 1.5 57 4.0 0.04 
Preterm, <37+0 weeks 28 13.7 65 4.6 <0.001 
Perinatal mortality 4 2.0 10 0.7 0.09 
Stillbirths 4 2.0 8 0.6 0.02 
Neonatal deaths 0 0.0 2 0.1 0.99 
1-minute Apgar score ≤ 6 13 6.4 73 5.2 0.47 
Delivery related asphyxia 5 2.5 35 2.5 0.99 
Phototherapy 19 9.3 63 4.4 0.003 
Neonatal intensive-care unit  8 3.9 38 2.7 0.32 
Neonatal status 7 days postpartum 
at home 169 82.8 1284 91.4 <0.001 
in hospital 31 15.2 111 7.9 
THR= total hip replacement, SD= standard deviation, LBW= low birthweight, LGA= large for gestational age, 
SGA= small for gestational age 
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Table 3 
Stillbirth Preterm SGA LBW 
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Univariable 3.52 (1.05-11.81) 3.31 (2.07-5.30) 3.21 (1.78-5.79) 4.67 (2.77-7.87) 
Adjusted* 2.72 (0.58-12.67) 3.58 (2.03-6.30) 2.83 (1.35-5.93) 4.79 (2.56-8.97) 
LBW= low birthweight, SGA= small for gestational age 
Table 4 
Patient group Control group 
Total number 135 1293 
n % n % P 
Mode of delivery 
spontaneous vaginal 93 68.9 1056 82.1 <0.001 
vacuum or forceps extraction 3 2.2 84 6.5 0.05 
emergency caesarean section 39 28.9 150 11.6 <0.001 
labor analgesia 
epidural 23 17.0 334 25.8 0.03 
spinal 2 1.5 30 2.3 0.53 
paracervical 18 13.3 219 16.9 0.28 
amniotomy 33 24.4 516 39.9 <0.001 
oxytocin augmentation 39 28.9 467 36.1 0.10 
episiotomy 28 20.7 372 28.8 0.05 
manual placental removal 1 0.7 15 1.2 0.66 
uterine curettage 1 0.7 18 1.4 0.53 
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